Core Viewpoint - Yum Brands (YUM) is expected to report quarterly earnings of $1.78 per share, reflecting a year-over-year increase of 10.6%, with revenues projected at $2.47 billion, up 4.4% from the previous year [1]. Earnings Projections - Analysts have adjusted the consensus EPS estimate upward by 0.2% over the past 30 days, indicating a reassessment of initial projections [1][2]. Revenue Estimates - Total revenues from company sales are estimated to be $948.02 million, representing a year-over-year increase of 7.1% [4]. - Franchise and property revenues are projected to reach $987.03 million, indicating a 4.5% increase year-over-year [4]. - Franchise contributions for advertising and other services are expected to be $536.69 million, showing a 0.9% increase from the prior year [5]. - KFC Division's franchise contributions for advertising and other services are forecasted at $200.77 million, reflecting a 7.9% increase year-over-year [5]. Restaurant Metrics - The number of franchise and license restaurants in the KFC Division is expected to reach 33,411, up from 31,513 in the same quarter last year [6]. - Total restaurants in the Taco Bell Division are projected at 8,984, compared to 8,757 in the previous year [6]. - Company-owned Taco Bell restaurants are expected to total 642, up from 504 year-over-year [7]. - Franchise and license Taco Bell restaurants are estimated at 8,342, compared to 8,253 last year [7]. - Total restaurants in the Pizza Hut Division are expected to be 20,190, slightly down from 20,225 year-over-year [7]. - The total number of restaurants across all divisions is projected to reach 63,461, up from 61,346 in the previous year [8]. - Company-owned KFC restaurants are estimated at 488, compared to 468 last year [8]. Same-Store Sales - The consensus estimate for same-store sales growth in the Taco Bell Division is 5.8%, up from 5.0% year-over-year [8]. Stock Performance - Over the past month, Yum shares have returned +2.8%, outperforming the Zacks S&P 500 composite's +0.9% change [10].

Core Viewpoint - Amgen (AMGN) is expected to report quarterly earnings of $4.74 per share, a decline of 10.7% year-over-year, with revenues projected at $9.46 billion, reflecting a 4.2% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.1% over the past 30 days, indicating analysts have adjusted their projections positively [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between these revisions and short-term stock price performance [3]. Revenue and Product Sales Projections - Analysts predict 'Revenue- Other revenues' will reach $402.12 million, an increase of 8.7% from the prior-year quarter [5]. - 'Revenue- Product sales' is expected to be $9.04 billion, reflecting a 3.7% increase year-over-year [5]. - 'Product Sales- Vectibix- Total' is projected at $279.69 million, indicating a 13.7% increase from the previous year [5]. Specific Product Sales Estimates - 'Product Sales- Enbrel- Total' is estimated at $649.46 million, showing a significant decline of 36% year-over-year [6]. - 'Product Sales- Neulasta- U.S.' is projected at $56.02 million, down 22.2% from the year-ago quarter [6]. - 'Product Sales- Neulasta- ROW' is expected to reach $19.40 million, reflecting a 25.4% decline [6]. - 'Product Sales- BLINCYTO- ROW' is estimated at $152.62 million, an increase of 12.2% year-over-year [7]. - 'Product Sales- Repatha- U.S.' is projected at $442.32 million, indicating a substantial increase of 40.4% from the previous year [7]. - 'Product Sales- Repatha- ROW' is expected to be $360.19 million, reflecting a 23.8% increase [8]. - 'Product Sales- BLINCYTO- U.S.' is projected at $287.58 million, indicating a 17.4% increase [8]. - 'Product Sales- KYPROLIS- U.S.' is expected to reach $228.82 million, showing a slight decline of 3% year-over-year [8]. - 'Product Sales- KYPROLIS- ROW' is projected at $130.37 million, reflecting a 4.1% decline [9]. Stock Performance - Amgen shares have increased by 4.6% over the past month, outperforming the Zacks S&P 500 composite, which has risen by 0.8% [9].

Wall Street analysts forecast that Take-Two Interactive (TTWO) will report quarterly earnings of $0.83 per share in its upcoming release, pointing to a year-over-year increase of 15.3%. It is anticipated that revenues will amount to $1.59 billion, exhibiting an increase of 15.6% compared to the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this tim ...

Core Insights - Renasant reported a revenue of $278.52 million for the quarter ended December 2025, marking a 66.7% increase year-over-year, with an EPS of $0.91 compared to $0.73 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $269 million by 3.54%, and the EPS surpassed the consensus estimate of $0.80 by 13.75% [1] Financial Performance Metrics - Net Interest Margin was reported at 3.9%, slightly above the average estimate of 3.8% from three analysts [4] - The Efficiency Ratio (GAAP) was 60.2%, compared to the estimated 59.7% by three analysts [4] - Total Nonperforming Loans amounted to $176.02 million, exceeding the average estimate of $170.5 million from two analysts [4] - Annualized Net Loan Charge-offs as a percentage of average loans stood at 0.2%, matching the estimate from two analysts [4] - Total Nonperforming Assets were reported at $191.21 million, higher than the average estimate of $180.98 million from two analysts [4] - Average Balance of Total Interest-Earning Assets was $23.75 billion, slightly above the average estimate of $23.74 billion from two analysts [4] - Net Interest Income reached $227.39 million, surpassing the average estimate of $223.56 million from three analysts [4] - Net Interest Income (FTE) was reported at $232.36 million, exceeding the average estimate of $228.17 million from three analysts [4] - Total Noninterest Income was $51.13 million, higher than the average estimate of $45.43 million from three analysts [4] Stock Performance - Renasant shares returned +3.9% over the past month, outperforming the Zacks S&P 500 composite's +0.4% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

The upcoming report from Norfolk Southern (NSC) is expected to reveal quarterly earnings of $2.78 per share, indicating a decline of 8.6% compared to the year-ago period. Analysts forecast revenues of $3 billion, representing a decline of 0.8% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 3.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timefr ...

Core Viewpoint - KLA (KLAC) is expected to report quarterly earnings of $8.82 per share, reflecting a 7.6% increase year-over-year, with revenues projected at $3.26 billion, a 6.1% increase compared to the previous year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for the quarter has been revised upward by 0.3%, indicating analysts' reassessment of their initial forecasts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Specialty Semiconductor Process' will reach $144.58 million, a decrease of 9.9% from the prior-year quarter [5]. - 'Revenues- Service' is projected at $751.55 million, indicating a year-over-year increase of 12.6% [5]. - 'Revenues- Product' is expected to be $2.49 billion, reflecting a 3.5% increase from the previous year [5]. - 'Revenues- Semiconductor Process Control' is estimated at $2.94 billion, showing a year-over-year increase of 6.7% [6]. - 'Revenues- PCB and Component Inspection' is forecasted at $159.69 million, a slight decrease of 0.9% year-over-year [6]. Geographic Revenue Insights - 'Geographic Revenues- China' is expected to reach $921.82 million, a decrease of 15.6% from the prior-year quarter [6]. - 'Geographic Revenues- Rest of Asia' is projected at $113.21 million, indicating a year-over-year increase of 17.2% [7]. - 'Geographic Revenues- North America' is forecasted to be $291.08 million, reflecting a 1.7% increase from the previous year [7]. - 'Geographic Revenues- Europe & Israel' is expected to be $145.56 million, a year-over-year increase of 8.4% [8]. - 'Geographic Revenues- Taiwan' is projected at $808.53 million, indicating a decrease of 8.3% year-over-year [8]. - 'Geographic Revenues- Korea' is expected to reach $630.80 million, reflecting a significant increase of 76.5% from the prior-year quarter [8]. - 'Geographic Revenues- Japan' is projected at $323.43 million, indicating a year-over-year increase of 41.5% [9]. Stock Performance - KLA shares have returned +18.2% over the past month, significantly outperforming the Zacks S&P 500 composite, which saw a change of +0.2% [9]. - KLA holds a Zacks Rank 1 (Strong Buy), indicating expectations to outperform the overall market in the near future [10].

Core Viewpoint - Analysts forecast that Visa will report quarterly earnings of $3.14 per share, reflecting a year-over-year increase of 14.2%, with revenues expected to reach $10.69 billion, an increase of 12.4% compared to the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to stock performance, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [2] Key Metrics Projections - Analysts estimate 'Revenues- Service revenue' at $4.68 billion, indicating a year-over-year change of +11.2% [4] - The average prediction for 'Revenues- Data processing revenue' is $5.44 billion, reflecting a year-over-year change of +14.6% [4] - 'Revenues- Other revenue' is projected to be $1.09 billion, showing a change of +19.4% from the previous year [4] International and Total Payments Volume - 'Revenues- International transaction revenue' is expected to reach $3.85 billion, suggesting a year-over-year increase of +11.8% [5] - 'End of Period Connections - Total transactions' is projected to be 69.85 billion, up from 63.80 billion year-over-year [5] - 'Payments volume - Total' is forecasted to reach $3828.52 billion, compared to $3522.00 billion in the previous year [5] Regional Payments Volume - 'Payments volume - Canada' is estimated at $117.01 billion, up from $111.00 billion in the same quarter last year [6] - 'Payments volume - CEMEA' is projected at $244.88 billion, compared to $211.00 billion in the same quarter of the previous year [6] - 'Payments volume - LAC' is expected to reach $277.20 billion, compared to $242.00 billion year-over-year [7] - 'Payments volume - U.S.A' is estimated at $1834.14 billion, up from $1720.00 billion in the same quarter last year [8] - 'Payments volume - Europe' is projected to be $798.70 billion, compared to $714.00 billion in the previous year [8] Stock Performance - Visa shares have shown a return of -8.1% over the past month, while the Zacks S&P 500 composite has increased by +0.2%, with Visa expected to mirror the overall market performance in the near future [8]

Core Viewpoint - Teva Pharmaceutical Industries Ltd. (TEVA) is expected to report a quarterly earnings per share (EPS) of $0.64, reflecting a year-over-year decline of 9.9%, while revenues are anticipated to reach $4.34 billion, showing a 2.6% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 2.2% lower over the last 30 days, indicating a reevaluation by analysts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts forecast 'Revenue- API sales to third parties' to reach $154.37 million, indicating a 6.5% increase year-over-year [5]. - 'Revenue- COPAXONE- Total' is expected to be $63.50 million, reflecting a substantial decline of 48% year-over-year [5]. - 'Geographic Revenue- United States' is projected at $2.15 billion, suggesting an 8.6% increase year-over-year [5]. - 'Geographic Revenue- Europe' is estimated to be $1.32 billion, indicating a decrease of 2.7% from the prior year [6]. - 'Geographic Revenue- International Markets' is expected to be $625.03 million, reflecting a decline of 5.4% year-over-year [6]. Specific Revenue Metrics - 'Geographic Revenue- Europe- Respiratory products' is estimated at $57.29 million, down 6.1% from the previous year [7]. - 'Geographic Revenue- International Markets- Generic products' is projected at $446.04 million, indicating a decline of 10.3% year-over-year [7]. - 'Geographic Revenue- International Markets- COPAXONE' is expected to reach $5.14 million, reflecting a significant drop of 42.9% from the prior year [8]. - 'Geographic Revenue- United States- AJOVY' is projected at $70.98 million, indicating a year-over-year increase of 12.7% [8]. - 'Geographic Revenue- Europe- Generic products' is expected to be $1.01 billion, reflecting a 2.9% increase year-over-year [9]. - 'Geographic Revenue- Europe- AJOVY' is projected at $74.75 million, indicating a substantial increase of 28.9% from the prior year [9]. - 'Geographic Revenue- Europe- Other' is estimated at $168.65 million, reflecting a decline of 17.7% from the previous year [9]. Stock Performance - Teva's shares have shown a return of -0.3% over the past month, compared to a +0.6% change in the Zacks S&P 500 composite [10].

Core Insights - Wall Street analysts anticipate Amphenol (APH) will report quarterly earnings of $0.93 per share, reflecting a year-over-year increase of 69.1% [1] - Expected revenues for the quarter are projected at $5.84 billion, which represents a 35.2% increase from the same quarter last year [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating stability in analysts' forecasts [1] Revenue Estimates - Analysts estimate 'Net Sales- Harsh Environment Solutions' will reach $1.50 billion, indicating a year-over-year change of +19.1% [4] - 'Net Sales- Interconnect and Sensor Systems' is projected to be $1.35 billion, reflecting a year-over-year increase of +19.6% [4] - 'Net Sales- Communications Solutions' is expected to reach $3.25 billion, suggesting a significant year-over-year change of +68.6% [5] Operating Income Estimates - 'Operating Income- Interconnect and Sensor Systems' is forecasted to be $406.22 million, compared to $209.60 million in the same quarter last year [5] - 'Operating Income- Communications Solutions' is estimated at $934.68 million, up from $501.90 million reported in the same quarter last year [6] - 'Operating Income- Harsh Environment Solutions' is projected to reach $361.46 million, compared to $305.40 million in the same quarter last year [6] Stock Performance - Amphenol shares have shown a return of +10.6% over the past month, outperforming the Zacks S&P 500 composite, which increased by +0.6% [6] - The company holds a Zacks Rank 1 (Strong Buy), indicating expectations of beating overall market performance in the near future [6]

Core Viewpoint - Community Trust Bancorp (CTBI) demonstrated strong financial performance for the quarter ended December 2025, with significant year-over-year growth in revenue and earnings per share (EPS) [1] Financial Performance - Revenue for the quarter was reported at $74.72 million, reflecting a 13.3% increase compared to the same period last year [1] - EPS was reported at $1.51, an increase from $1.25 in the year-ago quarter, resulting in a surprise of +5.97% over the consensus estimate of $1.43 [1] - The revenue exceeded the Zacks Consensus Estimate of $73.15 million by +2.15% [1] Key Metrics - Efficiency ratio stood at 48.7%, better than the average estimate of 50.5% based on two analysts [4] - Net Interest Margin was reported at 3.7%, slightly above the average estimate of 3.6% [4] - Average Balances of Interest-earning assets were $6.32 billion, compared to the estimated $6.29 billion [4] - Total Non-Interest Income was $16.6 million, surpassing the average estimate of $16 million [4] - Net Interest Income reached $58.12 million, exceeding the average estimate of $57.2 million [4] Stock Performance - Shares of Community Trust Bancorp have returned +1.4% over the past month, contrasting with the Zacks S&P 500 composite's -0.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]